Cardiac Valve Replacement

I Complications of Cardiac Valve Replacements and Their Treatment.- 1. Following the patient with prosthetic heart valves.- 2. Thromboembolism after cardiac valve replacement.- 3. Nonprosthetic factors producing thromboembolism in patients with cardiac valve substitutes: their nature and the problems of assessing their role.- 4. Anticoagulant therapy and cardiac valvular surgery: Coumadin® and other alternatives.- 5. Reoperation after cardiac valve surgery: elective, urgent and emergent.- Discussion.- II Cardiac Valve Substitutes: Current Status.- 6. Clinical experience with the caged-ball Starr-Edwards® prosthesis.- 7. Overview of experience with the Björk-Shiley® valve.- 8. Experience with standard and supra-annular Carpentier-Edwards® porcine bioprostheses.- 9. Aortic valve replacement with the Ionescu-Shiley® bovine pericardial valve: an 81-month experience.- Discussion.- III Cardiac Valve Replacement in Special Circumstances.- 10. Annuloaortic ectasia: surgical repair using a composite St. Jude Medical® valve and Dacron® tube graft.- 11. Valve replacement in the geriatric patient using the St. Jude Medical® prosthesis.- 12. Tricuspid valve replacement—a comparative experience with different valve substitutes.- 13. Double valve replacement.- 14. Cardiac valve replacement in the presence of coronary atherosclerosis.- Discussion.- IV Cardiac Valve Replacement in Pediatric Practice: Experience with the St. Jude Medical® Valve.- 15. St. Jude Medical® valve replacement in infants and children.- 16. Pediatric use of the St. Jude Medical® prosthesis.- 17. Mitral valve replacement in a child using the St. Jude Medical® valve.- 18. Thromboembolism in children with St. Jude Medical® valves maintained on aspirin and Persantine®.- Discussion.- V IntermediateFollow-up of Patients with St. Jude Medical® Prostheses: 52 to 72 Months.- 19. A 52-month experience with the St. Jude Medical® cardiac prosthesis at the Medical University of South Carolina.- 20. A 57-month experience with the St. Jude Medical® cardiac prosthesis at Hahnemann University Hospital.- 21. Incidence of complication with the St. Jude Medical® prosthesis: a 58-month study at Hamot Medical Center.- 22. Mitral valve replacement with St. Jude Medical® prostheses: a 60-month study of 350 cases at Centre Hospitalier Universitaire.- 23. A 60-month experience with the St. Jude Medical® prosthesis at Cedars-Sinai Medical Center.- 24. A 60-month experience with the St. Jude Medical® prosthesis at University Hospital, Brugmann.- 25. A 72-month clinical experience with the St. Jude Medical® cardiac valve prosthesis at Newark Beth Israel Medical Center.- 26. A 72-month experience with the St. Jude Medical® cardiac valve prosthesis at the Minneapolis Heart Institute and United Hospitals, St. Paul, Minnesota.- 27. A 72-month clinical experience with the St. Jude Medical® prosthesis at Tucson Medical Center.- Discussion.- VI Clinical Experience with Current Cardiac Valve Substitutes: Comparative Observations.- 28. Late complications in patients with Björk-Shiley® and St. Jude Medical® prostheses.- 29. Experience with the St. Jude Medical® valve and the Ionescu-Shiley® bovine pericardial valve at the Texas Heart Institute.- 30. Comparative assessment of single Björk-Shiley®, Hancock® and St. Jude Medical® valves at 43 months after operation.- Discussion.- VII Clinical Forum.- 31. Noninvasive assessment of prosthetic heart valve function by continuous-wave doppler ultrasound.- 32. Potential for immobilization of the valve occluder in various valveprostheses.- 33. Escape of a leaflet from a St. Jude Medical® prosthesis in the mitral position.- 34. Prophylaxis against thromboembolism using aspirin and dipyridamole in patients with the St. Jude Medical® aortic prosthesis.- Discussion.- VIII Closing Observations.- 35. Summary and concluding remarks.- 36. Summary and concluding observations.